CLOCK and diabetes mellitus: In this longitudinal study, we focused on individuals with diabetes and pre-diabetes, comprehensively evaluating the impact of ten epigenetic clock accelerations, including AgeAccelGrim2 and DunedinPoAm, on long-term outcomes.